Cite
HARVARD Citation
Hennessy, M. et al. (2021). Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma. International journal of cancer. 148 (8), pp. 1928-1937. [Online].